UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 129

Sortiert nach

Ghrelin Is Produced by the Human Erythroleukemic HEL Cell Line and Involved in an Autocrine Pathway Leading to Cell Proliferation

Endocrinology (Philadelphia), 2005-03, Vol.146 (3), p.1514-1522

2005

Volltextzugriff (PDF)

In vitro properties of a high affinity selective antagonist of the VIP1 receptor

Peptides (New York, N.Y. : 1980), 1997, Vol.18 (10), p.1555-1560

1997

Volltextzugriff (PDF)

Development of high affinity selective VIP1 receptor agonists

Peptides (New York, N.Y. : 1980), 1997, Vol.18 (10), p.1539-1545

1997

Volltextzugriff (PDF)

Different Vasoactive Intestinal Polypeptide Receptor Domains Are Involved in the Selective Recognition of Two VPAC2-Selective Ligands

Molecular pharmacology, 1999-12, Vol.56 (6), p.1280

1999

Volltextzugriff (PDF)

Fragments of pituitary adenylate cyclase activating polypeptide discriminate between type I and II recombinant receptors

European journal of pharmacology, 1995-12, Vol.287 (1), p.7-11

1995

Volltextzugriff (PDF)

Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4-2J

FEBS letters, 1990-03, Vol.262 (1), p.77-81

1990

Volltextzugriff (PDF)

Properties and distribution of receptors for pituitary adenylate cyclase activating peptide (PACAP) in rat brain and spinal cord

Regulatory peptides, 1991-08, Vol.35 (2), p.161-173

1991

Volltextzugriff (PDF)

Characterization of a novel VPAC1 selective agonist and identification of the receptor domains implicated in the carboxyl‐terminal peptide recognition

British journal of pharmacology, 2000-06, Vol.130 (4), p.819-826

2000

Volltextzugriff (PDF)

Properties of the VIP-PACAP type II receptor stably expressed in CHO cells

Regulatory peptides, 1994-12, Vol.54 (2), p.397-407

1994

Volltextzugriff (PDF)

Stimulation of rat pancreatic tumoral AR4-2J cell proliferation by Pituitary Adenylate cyclase-activating peptide

Gastroenterology (New York, N.Y. 1943), 1992-09, Vol.103 (3), p.1002-1008

1992

Volltextzugriff (PDF)

Ala-scan of ghrelin (1–14): interaction with the recombinant human ghrelin receptor

Peptides (New York, N.Y. : 1980), 2004-06, Vol.25 (6), p.959-965

2004

Volltextzugriff (PDF)

Characterization of a novel VPAC 1 selective agonist and identification of the receptor domains implicated in the carboxyl‐terminal peptide recognition

British journal of pharmacology, 2009-01, Vol.130 (4), p.819-826

2009

Volltextzugriff (PDF)

The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclass

Peptides (New York, N.Y. : 1980), 1997, Vol.18 (3), p.403-408

1997

Volltextzugriff (PDF)

The Long-Acting Vasoactive Intestinal Polypeptide Agonist RO 25-1553 Is Highly Selective of the VIP 2 Receptor Subclass

Peptides (New York, N.Y. : 1980), 1997, Vol.18 (3), p.403-408

1997

Volltextzugriff (PDF)

Hexanoylation of a VPAC2 receptor-preferring ligand markedly increased its selectivity and potency

Peptides (New York, N.Y. : 1980), 2004-02, Vol.25 (2), p.275-278

2004

Volltextzugriff (PDF)

Properties of a recombinant human secretin receptor : A comparison with the rat and rabbit receptors

Pancreas, 1999-07, Vol.19 (1), p.51-55

1999

Volltextzugriff (PDF)

Contribution of the second transmembrane helix of the secretin receptor to the positioning of secretin

FEBS letters, 1998-03, Vol.424 (3), p.207-210

1998

Volltextzugriff (PDF)

Propylbenzilylcholine mustard is selective for rat heart muscarinic receptors having a low affinity for agonists

British journal of pharmacology, 1986-05, Vol.88 (1), p.63-70

1986

Volltextzugriff (PDF)

The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors

Peptides (New York, N.Y. : 1980), 1996, Vol.17 (5), p.825-829

1996

Volltextzugriff (PDF)

Hexanoylation of a VPAC 2 receptor-preferring ligand markedly increased its selectivity and potency

Peptides (New York, N.Y. : 1980), 2004, Vol.25 (2), p.275-278

2004

Volltextzugriff (PDF)

Properties of Chimeric Secretin and VIP Receptor Proteins Indicate the Importance of the N-Terminal Domain for Ligand Discrimination

Biochemical and biophysical research communications, 1995-06, Vol.211 (3), p.885-891

1995

Volltextzugriff (PDF)

VPAC1 receptors have different agonist efficacy profiles on membrane and intact cells

Cellular signalling, 2002-08, Vol.14 (8), p.689-694

2002

Volltextzugriff (PDF)

Vasoactive intestinal polypeptide receptor VPAC1 subtype is predominant in rat prostate membranes

The Prostate, 1999-09, Vol.41 (1), p.1-6

1999

Volltextzugriff (PDF)

Interaction of lipophilic VIP derivatives with recombinant VIP1/PACAP and VIP2/PACAP receptors

European journal of pharmacology, 1998-07, Vol.354 (1), p.105-111

1998

Volltextzugriff (PDF)

Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states

Molecular pharmacology, 1996-12, Vol.50 (6), p.1596-1604

1996

Volltextzugriff (PDF)

1 – 25 von 129

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(125)
Mit Volltextzugriff
(113)

Publikationsform

Artikel
(127)
Bücher
(2)

Sprache

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ghrelin Is Produced by the Human Erythroleukemic HEL Cell Line and Involved in an Autocrine Pathway Leading to Cell Proliferation

In vitro properties of a high affinity selective antagonist of the VIP1 receptor

Development of high affinity selective VIP1 receptor agonists

Different Vasoactive Intestinal Polypeptide Receptor Domains Are Involved in the Selective Recognition of Two VPAC2-Selective Ligands

Fragments of pituitary adenylate cyclase activating polypeptide discriminate between type I and II recombinant receptors

Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4-2J

Properties and distribution of receptors for pituitary adenylate cyclase activating peptide (PACAP) in rat brain and spinal cord

Characterization of a novel VPAC1 selective agonist and identification of the receptor domains implicated in the carboxyl‐terminal peptide recognition

Properties of the VIP-PACAP type II receptor stably expressed in CHO cells

Stimulation of rat pancreatic tumoral AR4-2J cell proliferation by Pituitary Adenylate cyclase-activating peptide

Ala-scan of ghrelin (1–14): interaction with the recombinant human ghrelin receptor

Characterization of a novel VPAC 1 selective agonist and identification of the receptor domains implicated in the carboxyl‐terminal peptide recognition

The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclass

The Long-Acting Vasoactive Intestinal Polypeptide Agonist RO 25-1553 Is Highly Selective of the VIP 2 Receptor Subclass

Hexanoylation of a VPAC2 receptor-preferring ligand markedly increased its selectivity and potency

Properties of a recombinant human secretin receptor : A comparison with the rat and rabbit receptors

Contribution of the second transmembrane helix of the secretin receptor to the positioning of secretin

Propylbenzilylcholine mustard is selective for rat heart muscarinic receptors having a low affinity for agonists

The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors

Hexanoylation of a VPAC 2 receptor-preferring ligand markedly increased its selectivity and potency

Properties of Chimeric Secretin and VIP Receptor Proteins Indicate the Importance of the N-Terminal Domain for Ligand Discrimination

VPAC1 receptors have different agonist efficacy profiles on membrane and intact cells

Vasoactive intestinal polypeptide receptor VPAC1 subtype is predominant in rat prostate membranes

Interaction of lipophilic VIP derivatives with recombinant VIP1/PACAP and VIP2/PACAP receptors

Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states

Suchergebnisse filtern